Home/Filings/4/0001437749-19-002145
4//SEC Filing

Robbins Jim B 4

Accession 0001437749-19-002145

CIK 0000879682other

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 3:53 PM ET

Size

4.8 KB

Accession

0001437749-19-002145

Insider Transaction Report

Form 4
Period: 2019-01-29
Robbins Jim B
Vice President of Finance
Transactions
  • Award

    Common Stock

    2019-01-29+27,778145,346 total
Footnotes (1)
  • [F1]The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan (the "Plan") and received a restricted stock award of 27,778 shares of common stock on January 29, 2019 (the "Grant Date"). The restricted stock award shall vest in full upon the FDA approval of the Viveve System for improvement of sexual function or stress urinary incontinence (SUI) in the United States.

Issuer

VIVEVE MEDICAL, INC.

CIK 0000879682

Entity typeother

Related Parties

1
  • filerCIK 0001367881

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 3:53 PM ET
Size
4.8 KB